A new study published online by JAMA Oncology examines the prevalence and significance of estrogen receptor mutations in patients with metastatic breast cancer.
Aug 11, 2016
0
3
Published in JAMA Oncology, Principal Investigator of Vall d´Hebron Institute of Oncology´s (VHIO) Translational Genomics Group, Team Leader of translational genomics and targeted therapeutics in solid tumors at the August ...
Jun 9, 2016
0
4
A crowd-sourcing strategy aimed at accelerating research into metastatic breast cancer has connected advocacy groups, social media, and a dedicated web site to register more than 2,000 patients from all 50 states in its first ...
Jun 6, 2016
0
22
At any given moment, the human genome spells out thousands of genetic words telling our cells which proteins to make. Each word is read by a molecule known as a tRNA.
Jun 2, 2016
0
56
The National Cancer Moonshot initiative needs to move beyond genomics to target the proteins that are driving cancer, according to an Inova Health System and George Mason University collaborative paper published Thursday ...
May 23, 2016
1
4
"Cure" is a word that's dominated the rhetoric in the war on cancer for decades. But it's a word that medical professionals tend to avoid. While the American Cancer Society reports that cancer treatment has improved markedly ...
May 20, 2016
0
8
In a new study using mice and lab-grown human cells, a scientific team led by Johns Hopkins Kimmel Cancer Center researchers show how a triple-drug cocktail can shrink triple-negative breast cancers by killing off cancer ...
May 19, 2016
0
2
(HealthDay)—More than one in three women with metastatic breast cancer (MBC) are extreme users of disease-monitoring tests, with higher total health care costs seen in association with extreme use, according to a study ...
May 12, 2016
0
3
Conventional chemotherapy generally fails to eradicate aggressive breast cancers due to the early distant metastasis that can occur in these diseases. Triple-negative breast cancer (TNBC) is a particularly aggressive subtype ...
May 12, 2016
0
86
The molecularly targeted therapeutic palbociclib (Ibrance), which is used to treat advanced breast cancer, was effective in slowing the multiplication of cancer cells in patients diagnosed with early-stage breast cancer who ...
Apr 19, 2016
0
3
